Tubulin beta class I pseudogene 10 (TUBBP10)

Tubulin beta class I pseudogene 10 (TUBBP10) is a pseudogene, which means it is a DNA sequence similar to the functional tubulin beta class I gene but contains defects (such as frameshifts or premature stop codons) that prevent it from encoding a functional protein[1][2][6][8]. Pseudogenes are traditionally described as non-functional relics of protein-coding genes; they do not produce active proteins and typically do not serve as receptors, enzymes, or other druggable molecular targets[4][6][8]. While a small minority of pseudogenes in the human genome have been shown to produce transcripts or peptides with regulatory or pathological impact, most—including TUBBP10—are not translated or do not encode active proteins[1][6][8]. Thus, TUBBP10 is not considered a therapeutic target and should not be confused with its functional parental gene, TUBB (tubulin beta class I), which is a critical structural protein for microtubules[5][7]. Key clarifications: There is nothing to suggest that TUBBP10 functions as a receptor, enzyme, transporter, or protein-coding gene. It is a member of the class of pseudogenes that does not code for a protein and does not have a documented role in disease, drug interaction, biomarker utility, or drug mechanism[1][2][6]. The presence of “pseudogene” in the name and in authoritative resources like NCBI Gene and GeneCards confirms its annotation as a non-coding, non-protein, and thus non-druggable target[1][2]. Summary: TUBBP10 (tubulin beta class I pseudogene 10) is not a therapeutic target, has no protein product, and does not currently have any established biological function, disease association, drug interactions, or safety concerns[1][2][6][8]. The citation of this pseudogene as a target is likely incorrect for drug discovery or pharmacological studies.

Other names

TUBBP10